These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 21410716

  • 1. Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice.
    Doroud D, Zahedifard F, Vatanara A, Najafabadi AR, Rafati S.
    Parasite Immunol; 2011 Jun; 33(6):335-48. PubMed ID: 21410716
    [Abstract] [Full Text] [Related]

  • 2. C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c mice.
    Doroud D, Zahedifard F, Vatanara A, Taslimi Y, Vahabpour R, Torkashvand F, Vaziri B, Rouholamini Najafabadi A, Rafati S.
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1236. PubMed ID: 21765963
    [Abstract] [Full Text] [Related]

  • 3. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
    Zadeh-Vakili A, Taheri T, Taslimi Y, Doustdari F, Salmanian AH, Rafati S.
    Vaccine; 2004 May 07; 22(15-16):1930-40. PubMed ID: 15121305
    [Abstract] [Full Text] [Related]

  • 4. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
    Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T, Yokoyama N, Kojima N.
    Parasite Immunol; 2007 May 07; 29(5):229-39. PubMed ID: 17430546
    [Abstract] [Full Text] [Related]

  • 5. Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection.
    Doroud D, Zahedifard F, Vatanara A, Najafabadi AR, Taslimi Y, Vahabpour R, Torkashvand F, Vaziri B, Rafati S.
    J Control Release; 2011 Jul 30; 153(2):154-62. PubMed ID: 21530597
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 7. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J, Coombs GH, Mottram JC.
    J Immunol; 1998 Dec 15; 161(12):6794-801. PubMed ID: 9862710
    [Abstract] [Full Text] [Related]

  • 8. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr 15; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 9. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR.
    Trop Biomed; 2010 Dec 15; 27(3):639-50. PubMed ID: 21399606
    [Abstract] [Full Text] [Related]

  • 10. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.
    Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR.
    Vaccine; 2006 Jul 17; 24(29-30):5708-17. PubMed ID: 16740346
    [Abstract] [Full Text] [Related]

  • 11. Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.
    Badiee A, Jaafari MR, Khamesipour A.
    Exp Parasitol; 2007 Feb 17; 115(2):127-34. PubMed ID: 16979165
    [Abstract] [Full Text] [Related]

  • 12. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
    Rafati S, Zahedifard F, Azari MK, Taslimi Y, Taheri T.
    Exp Parasitol; 2008 Mar 17; 118(3):393-401. PubMed ID: 18093586
    [Abstract] [Full Text] [Related]

  • 13. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 14. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
    Tafaghodi M, Eskandari M, Khamesipour A, Jaafari MR.
    Exp Parasitol; 2011 Oct 01; 129(2):107-14. PubMed ID: 21767536
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S, Carrión J, Anderson C, Alonso C, Sacks D, Soto M.
    Infect Immun; 2005 Sep 01; 73(9):5842-52. PubMed ID: 16113303
    [Abstract] [Full Text] [Related]

  • 16. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 17. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F, Di Roberto RB, Gillard J, Cousineau B.
    Vaccine; 2012 Aug 24; 30(39):5726-32. PubMed ID: 22814408
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M.
    J Immunol; 1996 Jan 15; 156(2):644-52. PubMed ID: 8543816
    [Abstract] [Full Text] [Related]

  • 19. Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice.
    Rafati S, Ghaemimanesh F, Zahedifard F.
    Vaccine; 2006 Apr 12; 24(16):3290-7. PubMed ID: 16481076
    [Abstract] [Full Text] [Related]

  • 20. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.
    Okwor I, Liu D, Uzonna J.
    Vaccine; 2009 Apr 28; 27(19):2554-62. PubMed ID: 19428861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.